Artificial intelligence (AI) is no longer a future possibility for the life sciences industry, it is rapidly b...
Pune-based medtech firm Biorad Medisys announced the launch of Quantino 20W Thulium Fiber Laser for kidney sto...
Bengaluru-based startup 4baseCare has raised a total of Rs 128 crore ($13.3 million) in funding, co-led b...
India’s Diagnostics Shifts to SELF-RELIANCE & INNOVATION
There has been a flurry of activity in the Indian diagnostics space. In April 2026, C-CAMP hosted the first edition of the National Diagnostics Conclave and released the Indigenisation of Diagnostics (InDx) Guidance Manual, alongside initiatives aimed at strengthening domestic diagnostics capabilities. Government programmes such as the Free Diagnostics Service Initiative under the National Health Mission (NHM) continue to expand access to testing services. Diagnostics companies are also increasing investments in molecular diagnostics, genomics, AI-based ,automation and manufacturing. What explains this increased focus on diagnostics? What initiatives are being introduced by the government? How is the industry responding? And what additional support does the industry seek for the sector's next phase of growth?
For Feedback, please email us at: communications@mmactiv.com